Arix Bioscience Share Forecast, Price & News

Arix Bioscience (LON:ARIX) Frequently Asked Questions

Is Arix Bioscience a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Arix Bioscience stock.
View analyst ratings for Arix Bioscience or view top-rated stocks.

How has Arix Bioscience's stock price been impacted by COVID-19 (Coronavirus)?

Arix Bioscience's stock was trading at GBX 77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARIX shares have increased by 64.9% and is now trading at GBX 127.
View which stocks have been most impacted by COVID-19.

When is Arix Bioscience's next earnings date?

Arix Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Arix Bioscience.

What price target have analysts set for ARIX?

3 brokerages have issued twelve-month price targets for Arix Bioscience's stock. Their forecasts range from GBX 256 to GBX 256. On average, they anticipate Arix Bioscience's share price to reach GBX 256 in the next year. This suggests a possible upside of 101.6% from the stock's current price.
View analysts' price targets for Arix Bioscience or view top-rated stocks among Wall Street analysts.

Who are Arix Bioscience's key executives?

Arix Bioscience's management team includes the following people:

• Mr. Robert Lyne, Interim CEO, Gen. Counsel, Company Sec. & Director
• Mr. Marcus Karia, Group Fin. Director
• Ms. Charlotte Parry, Head of Investor Relations
• Dr. Christian Schetter, Managing Director (Age 57)
• Mr. John Cassidy Ph.D., Principal
• Mr. Tim Xu M.D., Principal
• Mr. Noor Lalani, Public Markets Investment Director
• Ms. Michelle Keating, Financial Controller
• Dr. Gita Dittmar, Venture Partner
• Mr. Felix Breyer Ph.D., Investment Analyst

Who are some of Arix Bioscience's key competitors?

Some companies that are related to Arix Bioscience include Ergomed (ERGO), Inventiva (IVA), Silence Therapeutics (SLN), Pfenex (PFNX), Synairgen (SNG), Theratechnologies (TH), ProMetic Life Sciences (PLI), Horizon Discovery Group plc (HZD.L) (HZD), VIVO Cannabis (ABCN), Emblem (EMC), Verona Pharma plc (VRP.L) (VRP), Redx Pharma (REDX), Agronomics (ANIC), Novacyt (NCYT) and BriaCell Therapeutics (BCT).
View all of ARIX's competitors.

What is Arix Bioscience's stock symbol?

Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX."

How do I buy shares of Arix Bioscience?

Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Arix Bioscience's stock price today?

One share of ARIX stock can currently be purchased for approximately GBX 127.

How much money does Arix Bioscience make?

Arix Bioscience has a market capitalization of £164.12 million and generates £60.68 million in revenue each year.

How many employees does Arix Bioscience have?

Arix Bioscience employs 12 workers across the globe.

What is Arix Bioscience's official website?

The official website for Arix Bioscience is arixbioscience.com.

Where are Arix Bioscience's headquarters?

Arix Bioscience is headquartered at 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom.

How can I contact Arix Bioscience?

Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050.